Alpha Particle Emitter Radiolabeled Antibodies in Cancer Therapy: Current Status, Challenges, and Future Prospects.

Pharmaceuticals (Basel) · 2025 · PMC12473050 · PMID 41011187

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

Although this study was simulated in preclinical studies, it might be significant for patients with EOC PC, as future studies focusing on refining targeting methods and enhancing therapeutic effects pave the way for clinical applications [ 71 ]. 7.5.

also in 2,457 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.